ArticleActa pharmacologica Sinica2025

JMC14: a novel dual PI3Kδ/CSF1R inhibitor with potent antitumor activity in hematological and solid tumors.

Xi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.